Professor Paul Haber
|
Area Medical Director
C39 - Royal Prince Alfred Hospital |
|
Current national competitive grants*
2011
Genetic risk factors for alcoholic cirrhosis - genome wide case control study
Seth D, Haber P, Nalpas B, Stickel F, Day C, Lumeng L, Morgan T, Whitfield J
NIH Research Support ($525,920 over 5 years)
Exploring the efficacy and biobehavioural basis of Baclofen in the treatment of alcoholic liver disease.
Haber P, Baille A
National Health and Medical Research Council Project Grant ($638,836 over 3 years)
* Grants administered through the University of Sydney
